Catabasis Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BNP PARIBAS ARBITRAGE, SNC | 11/12/2021 | 4.02 K | $24.88 K | 361.01% | 0.01% |
| JPMORGAN CHASE & CO | 11/12/2021 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 11/12/2021 | 0 | $0 | -100.00% | 0.00% |
| BARCLAYS PLC | 11/09/2021 | 0 | $0 | -100.00% | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2021 | 0 | $0 | -100.00% | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 11/02/2021 | 0 | $0 | -100.00% | 0.00% |
| OPPENHEIMER & CO INC | 11/12/2021 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 11/10/2021 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 01/20/2022 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2021 | 0 | $0 | -100.00% | 0.00% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/12/2021 | 0 | $0 | -100.00% | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 11/02/2021 | 0 | $0 | -100.00% | 0.00% |
| FEDERATED HERMES, INC. | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| AQR CAPITAL MANAGEMENT LLC | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2021 | 0 | $0 | -100.00% | 0.00% |
| PERCEPTIVE ADVISORS LLC | 12/03/2021 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| RA CAPITAL MANAGEMENT, L.P. | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 11/09/2021 | 0 | $0 | -100.00% | 0.00% |
| BANK OF NEW YORK MELLON CORP | 11/18/2021 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 11/02/2021 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| BOXER CAPITAL, LLC | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA ADVISERS, LP | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| ARCHPOINT INVESTORS | 11/12/2021 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 10/28/2021 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| CUTLER GROUP LLC / CA | 10/26/2021 | 0 | $0 | -100.00% | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| ERGOTELES LLC | 04/21/2022 | 0 | $0 | -100.00% | 0.00% |
| ACUTA CAPITAL PARTNERS, LLC | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| CORMORANT ASSET MANAGEMENT, LP | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/16/2021 | 0 | $0 | -100.00% | 0.00% |
| VR ADVISER, LLC | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/05/2021 | 0 | $0 | -100.00% | 0.00% |
| CORIENT CAPITAL PARTNERS, LLC | 11/16/2021 | 0 | $0 | -100.00% | 0.00% |
| TIBRA EQUITIES EUROPE LTD | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| SAMSARA BIOCAPITAL, LLC | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Catabasis Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of Catabasis Pharmaceuticals, Inc.. The most heavily invested institutionals were:
XTX MARKETS LLC: 26,041
LADENBURG THALMANN FINANCIAL SERVICES INC.: 126
Jump Trading, LLC: 23,573
0.01% of Catabasis Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 49.74 K shares in the last 24 months. This purchase volume represents approximately $424.78 K in transactions.